Precision BioSciences Inc (NASDAQ:DTIL)
| 11.97 Delayed Data As of Feb 26 |  +0.84 / +7.55%Today’s Change | 4.46 Today|||52-Week Range 16.60 | +43.53% Year-to-Date |
Latest DTIL News | Press Releases
No recent news for Precision BioSciences Inc.
Today’s Trading
| Previous close | 11.13 |
| Today’s open | 11.17 |
| Day’s range | 11.04 - 12.01 |
| Volume | 38,639 |
| Average volume (3 months) | 1,091,629 |
| Market cap | $628.7M |
Data as of 3:59pm ET, 02/26/2021
Growth & Valuation
| Earnings growth (last year) | -141.25% |
| Earnings growth (this year) | +1.23% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +104.34% |
| P/E ratio | NM |
| Price/Sales | 26.23 |
| Price/Book | 4.43 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HARPHarpoon Therapeutics... | +0.94 | +5.13% |
| MTEMMolecular Templates ... | -0.07 | -0.64% |
| MGTXMeiraGTx Holdings PL... | +0.06 | +0.40% |
| ALTAltimmune Inc | -1.25 | -7.27% |
Data as of 4:00pm ET, 02/26/2021
Financials
| Next reporting date | March 16, 2021 |
| EPS forecast (this quarter) | -$0.50 |
| Annual revenue (last year) | $22.2M |
| Annual profit (last year) | -$92.9M |
| Net profit margin | -417.65% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
